Literature DB >> 10628285

Neurotoxicity associated with suspected southern Pacific rattlesnake (Crotalus viridis helleri) envenomation.

S P Bush1, E Siedenburg.   

Abstract

An 18-year-old man was bitten on the hand by a snake he believed to be a Southern Pacific rattlesnake (Crotalus viridis helleri). Within minutes he developed generalized weakness, difficulty breathing, diplopia, dysphagia, and dysphonia. Neurological examination revealed ptosis and decreased motor strength. These symptoms partially improved after administration of Antivenin (Crotalidae) Polyvalent, but the patient continued to have difficulty walking for several days due to weakness. In addition to neurological symptoms, the patient also experienced pain immediately after the bite occurred and rapid swelling of the entire extremity, which extended beyond the shoulder. He complained of a metallic taste in his mouth and developed intense muscle fasciculations of the face, tongue, and upper extremities, which lasted for 2 days and did not improve with antivenin treatment. He exhibited laboratory evidence of coagulopathy and rhabdomyolysis. Although neurotoxins are known to occur in the venom of certain populations of rattlesnakes, only a few clinical reports describing severe neurological symptoms appear in the literature. To our knowledge, this is the first reported case of neurotoxicity associated with a suspected Southern Pacific rattlesnake envenomation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628285     DOI: 10.1580/1080-6032(1999)010[0247:nawssp]2.3.co;2

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  8 in total

1.  A case of neurotoxicity following envenomation by the Sidewinder rattlesnake, Crotalus cerastes.

Authors:  Adam R Bosak; Anne-Michelle Ruha; Kimberlie A Graeme
Journal:  J Med Toxicol       Date:  2014-06

2.  Crotalus helleri venom preconditioning reduces postoperative cerebral edema and improves neurological outcomes after surgical brain injury.

Authors:  Cherine H Kim; Devin W McBride; Prativa Sherchan; Carl E Person; Eric C K Gren; Wayne Kelln; Tim Lekic; William K Hayes; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2017-03-09       Impact factor: 5.996

Review 3.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

4.  Quantitative analysis of snake venoms using soluble polymer-based isotope labeling.

Authors:  Jacob A Galan; Minjie Guo; Elda E Sanchez; Esteban Cantu; Alexis Rodriguez-Acosta; John C Perez; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2007-12-18       Impact factor: 5.911

5.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.

Authors:  Eric J Lavonas; Anne-Michelle Ruha; William Banner; Vikhyat Bebarta; Jeffrey N Bernstein; Sean P Bush; William P Kerns; William H Richardson; Steven A Seifert; David A Tanen; Steve C Curry; Richard C Dart
Journal:  BMC Emerg Med       Date:  2011-02-03

6.  Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.

Authors:  Wojciech Waldman; Piotr M Kabata; Alison M Dines; David M Wood; Christopher Yates; Fridtjof Heyerdahl; Knut Erik Hovda; Isabelle Giraudon; Paul I Dargan; Jacek Sein Anand
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 7.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

8.  Perceptions, awareness on snakebite envenoming among the tribal community and health care providers of Dahanu block, Palghar District in Maharashtra, India.

Authors:  Itta Krishna Chaaithanya; Dipak Abnave; Himmatrao Bawaskar; Ujwal Pachalkar; Sandip Tarukar; Neha Salvi; Prabhakar Bhoye; Arun Yadav; Smita D Mahale; Rahul K Gajbhiye
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.